Fantao Meng
Technik-/Wissenschafts-/F&E-Leiter bei Hemoglobin Oxygen Therapeutics LLC
Profil
Fantao Meng is currently working as the Director of Research & Development at Hemoglobin Oxygen Therapeutics LLC.
He holds a doctorate degree from the Chinese Academy of Sciences.
Aktive Positionen von Fantao Meng
| Unternehmen | Position | Beginn |
|---|---|---|
Hemoglobin Oxygen Therapeutics LLC
 Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Fantao Meng
| Chinese Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Health Technology |
